Your browser doesn't support javascript.
loading
Evaluation of the usefulness of and satisfaction with the flash glucose monitoring system (FreeStyle Libre®) guide for use in patients with type 1 diabetes⋆.
Mateu-Salat, Manuel; Moreno-Fernández, Jesús; Mangas, Natalia; Genua, Idoia; Martínez, María José; López, Alicia; González, Cintia; Chico, Ana.
Afiliação
  • Mateu-Salat M; Servicio de Endocrinología y Nutrición, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
  • Moreno-Fernández J; Sección de Endocrinología y Nutrición, Hospital Universitario de Ciudad Real, Ciudad Real, Spain.
  • Mangas N; Servicio de Endocrinología y Nutrición, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
  • Genua I; Servicio de Endocrinología y Nutrición, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
  • Martínez MJ; Servicio de Endocrinología y Nutrición, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
  • López A; Servicio de Endocrinología y Nutrición, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
  • González C; Servicio de Endocrinología y Nutrición, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Madrid, Spain; Universitat Autònoma de Barcelona, Bellaterra, Barcelona, Spain.
  • Chico A; Servicio de Endocrinología y Nutrición, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. Electronic address: achicob@santpau.cat.
Endocrinol Diabetes Nutr (Engl Ed) ; 69(5): 316-321, 2022 May.
Article em En | MEDLINE | ID: mdl-35577748
ABSTRACT
The Flash Guide (FG) for insulin dosing (A. Chico, C. González) was the first document intended for FreeStyle Libre® (FSL) user patients to help with decision-making depending on glucose level and trend. The objective of the study was to evaluate the usefulness of and the level of satisfaction with the recommendations given by the FG in a group of patients with type 1 diabetes (DM1) who were FSL users. It included 31 subjects (54% women; age 41 ± 15 years; DM duration 21 ± 14 years; 22 with FSL > 12 months) who were provided with the FG. They completed a questionnaire on decision-making depending on glucose trend in different situations (before and three months after using the FG), and a satisfaction questionnaire (ad hoc). Demographic, clinical and glycaemic control data were collected. The percentage of subjects who used glucose trend in decision-making after receiving the FG increased for adjusting insulin (51 vs. 83; p = 0.016), action without insulin (51 vs. 90%; p = 0.001), and in special circumstances. The FG was evaluated as very useful (4.19/5). There were no significant changes in glycaemic control, although the percentage of data gathered increased significantly (89.07 vs. 94.46%; p = 0.042). In conclusion, the FG was evaluated well for managing glucose trends with FSL by the patients with DM1 analysed, increasing their use of trend in decision-making, with no changes in glycaemic control, but with more data gathered.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Glicemia / Automonitorização da Glicemia Tipo de estudo: Guideline / Prognostic_studies / Qualitative_research Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Endocrinol Diabetes Nutr (Engl Ed) Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Glicemia / Automonitorização da Glicemia Tipo de estudo: Guideline / Prognostic_studies / Qualitative_research Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Endocrinol Diabetes Nutr (Engl Ed) Ano de publicação: 2022 Tipo de documento: Article